Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 58

Sort by

Sort Order Select

Journal Articles

Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor

Sarah Haebe, Grady Day, Debra K. Czerwinski, Anuja Sathe, Susan M. Grimes, Tianqi Chen, Steven R. Long, Brock Martin, Michael G. Ozawa, Hanlee P. Ji, Tanaya Shree, Ronald Levy

Blood (2023) 142 (26): 2296–2304.

https://doi.org/10.1182/blood.2023020360

Published: 2023

Includes: Supplemental data

Journal Articles

Loss of the OX40 Target in Lymphoma Patients after Combining an Anti-OX40 Agonist Antibody with in Situ Vaccination

Debra K. Czerwinski, Tanaya Shree, Sarah Haebe, Shuyu Shi, Steven R Long, Brock Martin, Ronald Levy

Blood (2023) 142 (Supplement 1): 3020.

https://doi.org/10.1182/blood-2023-190189

Published: 2023

Journal Articles

Co-Occurrence of Clonally Related Follicular Lymphoma and Histiocytic Sarcoma

Sarah Haebe, Debra K. Czerwinski, Anuja Sathe, Susan Grimes, Tianqi Chen, Brock Martin, Hanlee Ji, Ronald Levy, Tanaya Shree

Blood (2023) 142 (Supplement 1): 6090.

https://doi.org/10.1182/blood-2023-189712

Published: 2023

Journal Articles

Prevalence of Acquired N-Glycosylation Sites at the Single Cell Level in Follicular Lymphoma

Sarah Haebe, Tanaya Shree, Grady Day, Debra K. Czerwinski, Anuja Sathe, Susan M. Grimes, Steven R. Long, Brock Martin, Michael G. Ozawa, Hanlee P. Ji, Ronald Levy

Blood (2022) 140 (Supplement 1): 9211–9212.

https://doi.org/10.1182/blood-2022-164763

Published: 2022

Journal Articles

Activating Immune Effectors and Dampening Immune Suppressors Generates Successful Therapeutic Cancer Vaccination in Patients with Lymphoma

Tanaya Shree, Sarah Haebe, Debra K. Czerwinski, Erik Eckhert, Grady Day, Anuja Sathe, Susan M. Grimes, Matthew J Frank, Lauren S. Maeda, Ash A. Alizadeh, Ranjana H. Advani, Richard Hoppe, Steven R. Long, Brock Martin, Michael G. Ozawa, Michael S. Khodadoust, Hanlee P. Ji, Ronald Levy

Blood (2022) 140 (Supplement 1): 6450–6451.

https://doi.org/10.1182/blood-2022-167469

Published: 2022

Journal Articles

In Situ Vaccination with IL-12Fc and TLR Agonist - a Crucial Role for B Cells in Generating Anti-Tumor T Cell Immunity

Idit Sagiv Barfi, Debra K. Czerwinski, Ronald Levy

Blood (2021) 138 (Supplement 1): 3514.

https://doi.org/10.1182/blood-2021-146628

Published: 2021

Journal Articles

Therapeutic and Immunologic Responses Elicited By in Situ Vaccination with CpG, Ibrutinib, and Low-Dose Radiation

Tanaya Shree, Sarah Haebe, Debra K. Czerwinski, Grady Day, Anuja Sathe, Michael S. Khodadoust, Matthew J. Frank, Sara Beygi, Richard Hoppe, Steven R. Long, Brock Martin, Hanlee P. Ji, Ronald Levy

Blood (2021) 138 (Supplement 1): 3539.

https://doi.org/10.1182/blood-2021-154017

Published: 2021

Journal Articles

In Situ Vaccination Induces Changes in Follicular Lymphoma Tumor Cells That Correlate with Abscopal Clinical Regressions

Sarah Haebe, Tanaya Shree, Grady Day, Anuja Sathe, Debra K. Czerwinski, Susan M. Grimes, Steven R. Long, Brock Martin, Richard Hoppe, Hanlee P. Ji, Ronald Levy

Blood (2021) 138 (Supplement 1): 2407.

https://doi.org/10.1182/blood-2021-154115

Published: 2021

Journal Articles

Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma

Tanaya Shree, Vishnu Shankar, Debra K. Czerwinski, Gladys Rodriguez, Sara Beygi, Joseph G Schroers-Martin, Ranjana Advani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, David M. Kurtz, Karen S. Corbelli, Etelka Gabriel, Alyssa M. Kanegai, Ash A. Alizadeh, Ronald Levy

Blood (2021) 138 (Supplement 1): 2064.

https://doi.org/10.1182/blood-2021-153901

Published: 2021

Journal Articles

Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma

Sarah Haebe, Tanaya Shree, Anuja Sathe, Grady Day, Debra K. Czerwinski, Susan M. Grimes, HoJoon Lee, Michael S. Binkley, Steven R. Long, Brock Martin, Hanlee P. Ji, Ronald Levy

Blood (2021) 137 (21): 2869–2880.

https://doi.org/10.1182/blood.2020009855

Published: 2021

Includes: Supplemental data

Journal Articles

Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma

Tanaya Shree, MDPhDBA, Michael S. Khodadoust, MD PhD, Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Sara Beygi, MD, Steven R. Long, MD, Brock Martin, MD, Ronald Levy, MD

Blood (2020) 136 (Supplement 1): 48.

https://doi.org/10.1182/blood-2020-141377

Published: 2020

Journal Articles

Single Cell Analysis of Serial Lymphoma Biopsies Reveals Dynamic Immune Modulation and Predictors of Response in Patients Undergoing in Situ Vaccination

Tanaya Shree, MDPhDBA, Sarah Haebe, MD, Anuja Sathe, PhD, Grady Day, Debra K. Czerwinski, BA, HoJoon Lee, PhD, Susan Grimes, BSc, Steven R. Long, MD, Brock Martin, MD, Hanlee Ji, MD, Ronald Levy, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-141672

Published: 2020

Journal Articles

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Tanaya Shree, MD PhD, Michael S. Khodadoust, MD PhD, Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Wan X. Hong, MD, Rachel Greenstein, Steven R. Long, MD, Brock Martin, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 2825.

https://doi.org/10.1182/blood-2019-129661

Published: 2019

Journal Articles

Site to Site Comparison of Follicular Lymphoma Biopsies By Single Cell RNA Sequencing

Sarah Haebe, MD, Tanaya Shree, MDPhDBA, Anuja Sathe, PhD, Grady Day, HoJoon Lee, PhD, Debra K. Czerwinski, BA, Susan Grimes, BSc, Hanlee Ji, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 297.

https://doi.org/10.1182/blood-2019-129445

Published: 2019

Journal Articles

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Tanaya Shree, MD PhD, Sarah Haebe, MD, Anuja Sathe, PhD, Grady Day, HoJoon Lee, PhD, Debra K. Czerwinski, BA, Susan Grimes, BSc, Hanlee Ji, MD, Ronald Levy, MD

Blood (2019) 134 (Supplement_1): 1479.

https://doi.org/10.1182/blood-2019-131684

Published: 2019

Journal Articles

Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints

Noemi Andor, Erin F. Simonds, Debra K. Czerwinski, Jiamin Chen, Susan M. Grimes, Christina Wood-Bouwens, Grace X. Y. Zheng, Matthew A. Kubit, Stephanie Greer, William A. Weiss, Ronald Levy, Hanlee P. Ji

Blood (2019) 133 (10): 1119–1129.

https://doi.org/10.1182/blood-2018-08-862292

Published: 2019

Includes: Supplemental data

Journal Articles

B-cell lymphomas present immunoglobulin neoantigens

Michael S. Khodadoust, Niclas Olsson, Binbin Chen, Brian Sworder, Tanaya Shree, Chih Long Liu, Lichao Zhang, Debra K. Czerwinski, Mark M. Davis, Ronald Levy, Joshua E. Elias, Ash A. Alizadeh

Blood (2019) 133 (8): 878–881.

https://doi.org/10.1182/blood-2018-06-845156

Published: 2019

Includes: Supplemental data

Journal Articles

In Situ Vaccination with Cpg and Anti-OX40 Antibody: Preclinical Optimization for Clinical Translation

Idit Sagiv Barfi, PhD, Debra K. Czerwinski, BA, Tanaya Shree, MD PhD BA, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 2943.

https://doi.org/10.1182/blood-2018-99-117872

Published: 2018

Journal Articles

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Tanaya Shree, MD PhD BA, Anuja Sathe, PhD, Debra K. Czerwinski, BA, Steven R. Long, MD, Hanlee Ji, MD, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 4107.

https://doi.org/10.1182/blood-2018-99-119925

Published: 2018

Journal Articles

Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and Non-Injected Tumor Sites in Patients with Low-Grade Lymphoma

Debra K. Czerwinski, BA, Matthew J. Frank, MD PhD, Tanaya Shree, MD PhD BA, Michael S Khodadoust, MD PhD, Steven R. Long, MD, Ronald Levy, MD

Blood (2018) 132 (Supplement 1): 1612.

https://doi.org/10.1182/blood-2018-99-119931

Published: 2018

NARROW

Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor

Loss of the OX40 Target in Lymphoma Patients after Combining an Anti-OX40 Agonist Antibody with in Situ Vaccination

Co-Occurrence of Clonally Related Follicular Lymphoma and Histiocytic Sarcoma

Prevalence of Acquired N-Glycosylation Sites at the Single Cell Level in Follicular Lymphoma

Activating Immune Effectors and Dampening Immune Suppressors Generates Successful Therapeutic Cancer Vaccination in Patients with Lymphoma

In Situ Vaccination with IL-12Fc and TLR Agonist - a Crucial Role for B Cells in Generating Anti-Tumor T Cell Immunity

Therapeutic and Immunologic Responses Elicited By in Situ Vaccination with CpG, Ibrutinib, and Low-Dose Radiation

In Situ Vaccination Induces Changes in Follicular Lymphoma Tumor Cells That Correlate with Abscopal Clinical Regressions

Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma

Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma

Intratumoral CpG, Local Radiation, and Oral Ibrutinib Combine to Produce Effective in Situ Vaccination in Patients with Low-Grade B-Cell Lymphoma

Single Cell Analysis of Serial Lymphoma Biopsies Reveals Dynamic Immune Modulation and Predictors of Response in Patients Undergoing in Situ Vaccination

A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma

Site to Site Comparison of Follicular Lymphoma Biopsies By Single Cell RNA Sequencing

Dynamic Immune Modulation Seen By Single Cell RNA-Sequencing of Serial Lymphoma Biopsies in Patients Undergoing in Situ Vaccination

Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints

B-cell lymphomas present immunoglobulin neoantigens

In Situ Vaccination with Cpg and Anti-OX40 Antibody: Preclinical Optimization for Clinical Translation

Single Cell RNA Sequencing of Serial Tumor and Blood Biopsies from Lymphoma Patients on an in Situ Vaccination Clinical Trial

Intratumoral Injection of CpG-ODN Plus Systemic Ibrutinib Induces an Anti-Tumor Immune Response Affecting T Cell Subsets in the Microenvironment of Both Injected and Non-Injected Tumor Sites in Patients with Low-Grade Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only